Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
May
11
2023
Florida Passes Bill to Allow Telehealth Renewals for Medical Marijuana Foley & Lardner LLP
May
10
2023
The Reagan Udall Foundation – A Critical Evaluation of FDA’s Center for Tobacco Products Keller and Heckman LLP
May
10
2023
HHS OIG Report: COVID-19 Testing Labs Flagged for Fraud Tycko & Zavareei LLP
May
10
2023
Teleprescribing of Controlled Substances Temporarily Extended Beyond Phe – What’s Next? McDermott Will & Emery
May
10
2023
Delta Great? Tennessee Legislature Passes Industry-Friendly Bill to Regulate Psychoactive, Hemp-Derived Cannabinoids Bradley Arant Boult Cummings LLP
May
10
2023
FDA Petitioned to Set Added Sugar Reduction Targets Keller and Heckman LLP
May
10
2023
FDA Filed Color Additive Petition Request to Revoke Listing for Use of Titanium Dioxide in Food; Notifies World Trade Organization Keller and Heckman LLP
May
10
2023
JRC Publishes Guidance Document on Implementation of the EC’s Revised Definition of Nanomaterials, Launches Free Course on Nanomaterials in EU Legislation Bergeson & Campbell, P.C.
May
9
2023
Podcast: The Legal Battle Over Mifepristone – Diagnosing Health Care [PODCAST] Epstein Becker & Green, P.C.
May
9
2023
Healthcare Preview For the Week Of: May 8, 2023 McDermott Will & Emery
May
8
2023
FDA Discusses International Food Safety Collaboration and Upcoming APEC Meetings Keller and Heckman LLP
May
5
2023
Roadmap to the Phased Transition Process for Medical Devices after Covid-19 Public Health Emergency Squire Patton Boggs (US) LLP
May
5
2023
Mcdermottplus Check-Up: May 5, 2023 McDermott Will & Emery
May
4
2023
FDA Seeks Comment on Request to Revoke the Color Additive Listing for Use of Titanium Dioxide in Food Bergeson & Campbell, P.C.
May
4
2023
EC Committee Begins Public Consultation on Preliminary Opinion on Fullerenes, Hydroxylated Fullerenes, and Hydrated Forms of Hydroxylated Fullerenes (Nano) Bergeson & Campbell, P.C.
May
4
2023
House Energy and Commerce Committee Introduces Food Labeling Modernization Act of 2023 Keller and Heckman LLP
May
4
2023
DEA to Extend Current Telemedicine Flexibilities Polsinelli PC
May
3
2023
AAFCO Announces Common Food Index Keller and Heckman LLP
May
3
2023
APHIS Releases New Strategic Plan for 2023-2027, Includes Biotechnology Objectives Bergeson & Campbell, P.C.
May
3
2023
Senate HELP Committee Eyes Drug Pricing and PBM Regulation Beyond Federal Programs Mintz
May
2
2023
CSU Announces Redesigned “Dream” Biodegradable Plastics Bergeson & Campbell, P.C.
May
2
2023
Court Upholds Dismissal of Lawsuit Challenging “Just Fruit” Claim Keller and Heckman LLP
May
2
2023
BREAKING: Seventh Circuit Affirms Dismissal of Lawsuit Alleging Violation of Genetic Right to Privacy, Rebuffing Claims Premised on Stock Purchase of Genetic Testing Company Squire Patton Boggs (US) LLP
May
2
2023
Unpacking Averages: Success Rates for FDA FOIAs by Topic and Requester Epstein Becker & Green, P.C.
May
2
2023
The Hydrogen Color Wheel: A Primer Blank Rome LLP
May
1
2023
EPA Denies Petition Seeking TSCA Section 4 Testing of PVA Bergeson & Campbell, P.C.
May
1
2023
Another Letter From Congress Complaining About Pharmaceutical Patents Foley & Lardner LLP
May
1
2023
SCOTUS Appears Poised To Reject Defense-Friendly Safeco Scienter Standard In FCA Cases Polsinelli PC
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins